Press releases
- Dexcom to Host Investor Day on June 23, 2023
- Dexcom Announces Upcoming Conference Presentation
- Dexcom Showcases Accuracy, Reliability and Ease of Use of Its Dexcom G6 CGM System at the 66th Annual Meeting of the Japan Diabetes Society
- Dexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028
- Dexcom rtCGM is Likely to be Cost-Saving, Study Suggests
- Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes
- Dexcom Reports First Quarter 2023 Financial Results
- Dexcom G6 Real-Time CGM System Now Accessible to Any Eligible Client Managing Diabetes With Insulin Through NIHB
- Dexcom Commends Decision to Expand CGM Medicare Coverage to Include People With Diabetes Using All Types of Insulin
- Dexcom Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023 at 4:30 p.m. Eastern Time
More ▼
Key statistics
On Wednesday, Dexcom Inc (DC4:STU) closed at 111.70, -9.28% below its 52-week high of 123.12, set on Oct 31, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 116.70 |
---|---|
High | 116.70 |
Low | 111.16 |
Bid | 111.76 |
Offer | 112.12 |
Previous close | 116.22 |
Average volume | 182.00 |
---|---|
Shares outstanding | 387.64m |
Free float | 384.65m |
P/E (TTM) | 173.47 |
Market cap | 46.40bn USD |
EPS (TTM) | 0.6901 USD |
Data delayed at least 15 minutes, as of Jun 07 2023.
More ▼